BVF INC/IL Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001056807
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 47 positions · Total reported value $3.04B · Top-10 concentration 66.0% · Updated 2026-11-17
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
Turnover: 41.7% · 4 new · 15 cut · 1 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -15.2% · vs SPY -17.3% · Prev Value $3.91B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -2.8% · vs SPY -5.0% · Latest Value $3.04B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, BVF INC/IL disclosed 47 equity positions with a combined reported value of $3.04B. The filing implies a focused portfolio: its ten largest positions account for 66.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were RVMD ($505.05M), KYMR ($432.86M), GHRS ($203.11M). By sector, the heaviest allocations are Health Care 99.4%, Financials 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+7.8pp) and away from Other (-7.9pp).
Versus the prior quarter, BVF INC/IL opened 4 new positions, trimmed 15 and fully exited 1, a turnover rate of 41.7% of positions. The portfolio's overlap with the prior quarter was 90% of names.
The largest new positions opened in Q3 2026 were PYXS ($27.55M), ALEC ($18.59M), TLGYF ($6.25M).
Of the 1 positions fully exited versus the prior quarter, the largest were XOMA ($322.72M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- XOMA XOMA ROYALTY CORPORATION · prev qtr: $322.72M
Insider Transactions (Form 4)
Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-14 | U | XOMA Royalty Corp | 772,000 | — | SEC filing |
| 2026-07-14 | U | XOMA Royalty Corp | 412,000 | — | SEC filing |
| 2026-07-14 | U | XOMA Royalty Corp | 2,773,545 | — | SEC filing |
| 2026-07-14 | U | XOMA Royalty Corp | 3,635,758 | — | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 51,858 | $106.50 | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 113,289 | $106.50 | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 627,597 | $106.50 | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 837,914 | $106.50 | SEC filing |
Fund Profile
BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 47 positions worth $3.04B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Portfolio Structure
- 47 positions · $3.04B reported value (Q3 2026)
- Top 10 holdings = 66.0% of reported value
- Largest position: RVMD (REVOLUTION MEDICINES INC) at 16.6%
- Average position size: $64.68M
Sector Tilt
- Health Care 99.4%
- Financials 0.2%
- Materials 0.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 4 new, 7 added, 15 reduced, 1 exited
- 21 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 09:54
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.46M | $505.05M | 16.61% | Reduce | |
| 2 |
|
3.87M | $432.86M | 14.24% | Hold | |
| 3 |
|
8.65M | $203.11M | 6.68% | Hold | |
| 4 |
|
16.00M | $187.22M | 6.16% | Hold | |
| 5 |
|
6.23M | $155.36M | 5.11% | Reduce | |
| 6 |
|
2.13M | $129.20M | 4.25% | Reduce | |
| 7 |
|
2.85M | $115.36M | 3.79% | Add | |
| 8 |
|
3.61M | $93.83M | 3.09% | Add | |
| 9 |
|
4.22M | $92.20M | 3.03% | Add | |
| 10 |
|
3.46M | $91.77M | 3.02% | Reduce | |
| 11 |
|
5.75M | $88.27M | 2.90% | Hold | |
| 12 |
|
2.69M | $84.16M | 2.77% | Reduce | |
| 13 |
|
607.15K | $83.74M | 2.75% | Reduce | |
| 14 |
|
6.69M | $71.65M | 2.36% | Reduce | |
| 15 |
|
19.82M | $51.93M | 1.71% | Hold | |
| 16 |
|
4.28M | $51.02M | 1.68% | Reduce | |
| 17 |
|
17.05M | $49.62M | 1.63% | Add | |
| 18 |
|
5.30M | $45.76M | 1.50% | Hold | |
| 19 |
|
3.09M | $45.14M | 1.49% | Add | |
| 20 |
|
2.88M | $41.20M | 1.35% | Hold | |
| 21 |
|
1.23M | $37.28M | 1.23% | Reduce | |
| 22 |
|
8.28M | $35.02M | 1.15% | Reduce | |
| 23 |
|
407.23K | $34.81M | 1.15% | Reduce | |
| 24 |
|
3.50M | $34.58M | 1.14% | Add | |
| 25 |
|
11.83M | $27.55M | 0.91% | New | |
| 26 |
|
2.36M | $25.44M | 0.84% | Hold | |
| 27 |
|
28.16M | $24.51M | 0.81% | Hold | |
| 28 |
|
3.00M | $23.31M | 0.77% | Hold | |
| 29 |
|
5.84M | $20.86M | 0.69% | Hold | |
| 30 |
|
1.25M | $20.17M | 0.66% | Hold | |
| 31 |
|
2.35M | $19.43M | 0.64% | Hold | |
| 32 |
|
10.05M | $18.59M | 0.61% | New | |
| 33 |
|
6.29M | $15.92M | 0.52% | Hold | |
| 34 |
|
233.30K | $15.27M | 0.50% | Reduce | |
| 35 |
|
907.41K | $13.91M | 0.46% | Reduce | |
| 36 |
|
4.05M | $11.02M | 0.36% | Add | |
| 37 |
|
765.29K | $7.12M | 0.23% | Hold | |
| 38 |
|
500.00K | $6.25M | 0.21% | New | |
| 39 |
|
500.00K | $5.92M | 0.20% | New | |
| 40 |
|
500.00K | $5.36M | 0.18% | Hold | |
| 41 |
|
1.35M | $5.19M | 0.17% | Hold | |
| 42 |
|
1.11M | $5.08M | 0.17% | Hold | |
| 43 |
|
1.58M | $4.57M | 0.15% | Reduce | |
| 44 |
|
686.04K | $2.53M | 0.08% | Hold | |
| 45 |
|
5.56M | $1.75M | 0.06% | Hold | |
| 46 |
|
945.40K | $189.18K | 0.01% | Hold | |
| 47 |
|
25.00K | $47.25K | 0.00% | Reduce | |
FAQ
What did BVF INC/IL buy in 2026-Q3?
In its 2026-Q3 13F filing, BVF INC/IL reported 47 equity positions worth $3.04B in aggregate; its largest disclosed positions were RVMD ($505.05M), KYMR ($432.86M), GHRS ($203.11M).
How large is BVF INC/IL's portfolio?
BVF INC/IL reported $3.04B of long equity holdings across 47 positions as of 2026-Q3. Top-10 holdings account for 66.0% of reported value.
What is BVF INC/IL's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.